News Release
BASEL, SWITZERLAND — Orthopedics company Medartis, with a location in Warsaw, announced Tuesday, June 11, that its chief executive officer, Christoph Brönnimann, has decided to resign from his position and leave the company to pursue other opportunities.
Brönnimann will continue to lead Medartis until a successor is ready to take over. The board has initiated a search for his successor.
“Under Christoph’s leadership, Medartis has significantly accelerated its growth in its key markets, broadened the product portfolio and strengthened its standing with leading surgeons and hospitals worldwide,” said Marco Gadola, Medartis chairman. “He has also expanded the capabilities of the organization and fostered an engaging culture, positioning the company for future success. This work will continue and growth remains our top priority.”
“While this has been a difficult decision for me,” said Brönnimann, “I am proud of what we have accomplished together over the past five years. I will leave behind a talented executive team, a passionate organization and a company with huge potential for future growth.”
Medartis is one of the world’s leading manufacturers and suppliers of medical devices for the surgical fixation of bone fractures in the upper and lower extremities and the craniomaxillofacial region. Medartis sells products worldwide and employs more than 860 people in 13 locations, including a location at 1195 Polk Drive, Warsaw.
Medartis was founded in 1997 and is headquartered in Basel, Switzerland. For more information, visit medartis.com.
